About this trial
Cervical spondylosis is one of the common causes of chronic neck pain. It can significantly affect the quality of life, lead to disabilities, and increase the economic burden on patients. Treatment mainly includes pain relievers, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants or physical therapy. The condition tends to recur frequently; therefore, long-term use of medication can lead to unwanted effects on the digestive system, kidneys, and cardiovascular system.
Dry cupping therapy is a non-pharmacological method that has been shown to be effective in pain management. Cupping therapy has the advantage of being applicable to patients who are afraid of needles and has a wide area of effect.
Given the limitations in evaluating treatment effectiveness and safety, along with the lack of published research discussing the analgesic effects of dry cupping for neck pain caused by cervical spondylosis, the investigators conducted the study on pain reduction and safety of cupping therapy in patients with neck pain caused by cervical spondylosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals between the ages of 20 and 60 years, outpatient treatment.
Individuals diagnosed with cervical spondylosis.
Individuals report pain intensity between 3 and 8 according to on the Visual Analogue Scale (VAS) on the screening visit day.
Experiencing neck pain for no longer than four weeks.
Disqualifiers
Patients diagnosed with acute or chronic neck pain due to specific causes or with root compression syndrome, spinal cord compression syndrome, or vertebral artery syndrome.
Patients loss of normal cervical curvature or deformity.
Individuals with a history of neck trauma, cervical vertebra fracture, or cervical spine surgery, congenital spinal abnormalities, systemic bone and joint diseases.
Patients have undergone cupping therapy, plastering, or drug inhalation within one week prior to participating in the study.
Trial design
Parallel
Treatments tested in this trial
Dry cupping therapy
Other interventionDry cupping therapy will perform on the skin areas containing the EX-B2, A-shi, and GB21 acupuncture points every 3 days for 2 weeks.
Electroacupuncture
Other interventionElectroacupuncture therapy will be performed five times a week for 2 weeks. The acupoints are the Huatuojiaji (EX-B2), A-shi, and Jianjing (GB21).
Treatment groups
Trial outcomes
Primary outcomes
The change of the Visual Analog Scale (VAS)
Symptom scores will be assessed based on a visual analogue scale (VAS). It usually consists of a 10 cm line anchored at each end by descriptors. Patients will be classified into 1 of 4 groups (no pain (0 cm), mild pain (1-3 cm), moderate pain (4-7 cm), severe pain (8-10 cm)).
Secondary outcomes
Proportion of intervention-related adverse events
While dry cupping therapy and electroacupuncture is generally considered safe, some patients may experience minor side effects at the application site. These can include ecchymosis or burns. Rarely, more serious complications like dizziness, headaches, and fatigue may occur. The study will closely monitor and document any unexpected adverse events associated with the procedure.
Active range of motion of the cervical spine
Active range of motion is measured using a goniometer. During measurement, the patient sits upright with hips and knees flexed at 90 degrees, both feet flat on the floor, and arms relaxed alongside the body. Cervical spine movements include flexion, extension, left and right lateral flexion, and left and right rotation.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: